DK0624374T3 - Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati - Google Patents

Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati

Info

Publication number
DK0624374T3
DK0624374T3 DK94107051T DK94107051T DK0624374T3 DK 0624374 T3 DK0624374 T3 DK 0624374T3 DK 94107051 T DK94107051 T DK 94107051T DK 94107051 T DK94107051 T DK 94107051T DK 0624374 T3 DK0624374 T3 DK 0624374T3
Authority
DK
Denmark
Prior art keywords
sulodexide
treatment
diabetic nephropathy
drugs containing
diabetic
Prior art date
Application number
DK94107051T
Other languages
Danish (da)
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Application granted granted Critical
Publication of DK0624374T3 publication Critical patent/DK0624374T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/38Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK94107051T 1993-05-10 1994-05-05 Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati DK0624374T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO930205A IT1270846B (it) 1993-05-10 1993-05-10 Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.

Publications (1)

Publication Number Publication Date
DK0624374T3 true DK0624374T3 (da) 2001-01-29

Family

ID=11339016

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94107051T DK0624374T3 (da) 1993-05-10 1994-05-05 Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati

Country Status (12)

Country Link
US (1) US5496807A (it)
EP (1) EP0624374B1 (it)
JP (1) JP2702400B2 (it)
KR (1) KR0165567B1 (it)
AT (1) ATE198278T1 (it)
CA (1) CA2120062C (it)
DE (1) DE69426471T2 (it)
DK (1) DK0624374T3 (it)
ES (1) ES2152272T3 (it)
GR (1) GR3035231T3 (it)
IT (1) IT1270846B (it)
PT (1) PT624374E (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
IT1299969B1 (it) * 1998-04-15 2000-04-04 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.
IL127896A0 (en) * 1998-12-31 1999-10-28 Gail Laster A novel treatment for preeclampsia and related diseases
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
MXPA03011514A (es) * 2001-06-12 2004-10-28 Keryx Biopharmaceuticals Inc Metodos que utilizan glucosaminoglicanos para tratamiento de nefropatia.
AU2005292202A1 (en) * 2004-10-01 2006-04-13 Keryx Biopharmaceuticals, Inc. Methods using glycosaminoglycans for the treatment of kidney disease
WO2006082643A1 (ja) 2005-02-03 2006-08-10 Taiyo Kagaku Co., Ltd. 糖尿病および/または糖尿病性腎症の予防、改善、または治療用組成物
EP1883412A4 (en) * 2005-05-05 2008-09-03 Keryx Biopharmaceuticals Inc COMBINATION THERAPY WITH SULODEXIDE AND A BLOOD PRESSURE WRITING AGENT IN THE TREATMENT OF DIABETIC NEPHROPATHY
MX2008008213A (es) * 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
KR20090035581A (ko) * 2006-08-04 2009-04-09 아지노모토 가부시키가이샤 신장 기능 장해 예방ㆍ치료제
WO2008070778A2 (en) * 2006-12-06 2008-06-12 Nephrogenex Inc. Pyridoxamine and low molecular weight heparinoids for diabetic kidney disease
EP2120905A1 (en) * 2006-12-22 2009-11-25 BELLUS Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
KR101923354B1 (ko) 2009-05-04 2018-11-28 프로메틱 파마 에스엠티 리미티드 치환된 방향족 화합물 및 그의 약학적 용도
CN103298777B (zh) 2010-10-27 2016-07-06 普罗米蒂克生物科学公司 苯基酮羧酸盐化合物和其药学用途
EP3833332A4 (en) 2018-07-13 2022-04-20 University of Miami METHODS OF TREATMENT OF KIDNEY DISEASE
US20200085810A1 (en) 2018-07-26 2020-03-19 Hoffmann-La Roche Inc. Compounds for use in treating kidney disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245761B (it) * 1991-01-30 1994-10-14 Alfa Wassermann Spa Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Also Published As

Publication number Publication date
GR3035231T3 (en) 2001-04-30
ITBO930205A0 (it) 1993-05-10
ITBO930205A1 (it) 1994-11-10
DE69426471D1 (de) 2001-02-01
US5496807A (en) 1996-03-05
PT624374E (pt) 2001-04-30
ES2152272T3 (es) 2001-02-01
JP2702400B2 (ja) 1998-01-21
DE69426471T2 (de) 2001-05-03
JPH06329541A (ja) 1994-11-29
EP0624374A1 (en) 1994-11-17
CA2120062A1 (en) 1994-11-11
ATE198278T1 (de) 2001-01-15
IT1270846B (it) 1997-05-13
CA2120062C (en) 1999-05-25
EP0624374B1 (en) 2000-12-27
KR0165567B1 (ko) 1999-01-15

Similar Documents

Publication Publication Date Title
DK0624374T3 (da) Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati
DK0600033T3 (da) Doseringsform til afgivelse af lægemiddel i et kort tidsrum
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ATE306266T1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
NO20055173L (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
BG101118A (en) Therapeutical compounds
ATE281171T1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
DE69531098D1 (de) Piperidine und pyrrolidine
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
HK1068606A1 (en) Novel aminobenzoephenones
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
ATE277907T1 (de) Blutzuckersenkende und lipidsenkende verbindungen
BR0017329A (pt) Formulção farmacêutica de um medicamento, uso de melatonina na fabricação de um medicamento, e, método para prevenção ou tratamento de sintomas de discinesia tardia em um paciente usanto tal medicamento
ATE344664T1 (de) Verbesserte methode zur eradikation von helicobacter pylori
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
EP0950413A3 (en) Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
BR0015329A (pt) Uso de óxido nìtrico para o tratamento de constrição das vias aéreas
BR9801839A (pt) Medicamento analgésico e aplicação de (+) -0-demetiltramadol.
Langloh Experience with piroxicam in general practice: results of a German multicenter study on 18,888 patients
BR0107935A (pt) Uso de rofleponida, seus ésteres e sais, método para tratar um paciente que sofre de sìndrome do intestino irritável, e, formulação farmacêutica para uso no tratamento da sìndrome do intestino irritável
NO964783D0 (no) Farmasöytisk sammensetning, produkt for personlig medisinering og fremgangsmåte for behandling av pasienter med infeksjoner